Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in Australia
42 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Active, not recruitingSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Adelaide, Clayton, Randwick, Southport
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Melbourne, Randwick, South Brisbane, Sydney
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 3Taking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
- Age
- 18 years and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 1Taking peopleStudy of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Clayton, Perth, Sydney, Westmead, Woolloongabba
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06974110 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Perth, Sydney
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 2Taking peopleA Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
- Where
- Albury, Bedford Park, Fitzroy, Garran, Herston, Melbourne, Nedlands, Newcastle
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06290505 - Phase 1Taking peopleStudy of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
- Where
- Adelaide, Melbourne, Sydney
- Age
- 18 years to 85 years
- People
- 70
- Run by
- ImmVirx Pty Ltd
See details and how to joinNCT05427487 - No phaseNot yet taking people in AustraliaThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 3Taking peopleA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Where
- Campbelltown, Concord, Fitzroy, Frankston, Gosford, North Ryde, Sunshine Coast
- Age
- 18 years and over
- People
- 550 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06532006 · EU 2024-516633-12-00 - Phase 1/2Taking peopleA First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
- Where
- Birtinya, Clayton, Darlinghurst, Heidelberg, Westmead
- Age
- 18 years and over
- People
- 122 worldwide
- Run by
- Bolt Biotherapeutics, Inc.
See details and how to joinNCT06921837 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Melbourne
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleThe Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
- Where
- Sydney
- Age
- 18 years and over
- People
- 500
- Run by
- Western Sydney Local Health District
See details and how to joinNCT05804331 - No phaseNot yet taking people in AustraliaTextbook Outcomes After Oesophagectomy in Regional Australia
- Where
- Launceston
- People
- 100
- Run by
- Launceston General Hospital
See details and how to joinNCT06721715 - No phaseNot yet taking people in AustraliaPost Oesophagectomy Outcomes in a Single Regional Centre in Australia
- Where
- Launceston
- People
- 100
- Run by
- Launceston General Hospital
See details and how to joinNCT06662513 - Phase 1Taking peopleStudy of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
- Where
- Bedford Park, Darlinghurst, Malvern, Nedlands, Randwick, Westmead
- Age
- 18 years and over
- People
- 48
- Run by
- Myeloid Therapeutics
See details and how to joinNCT05969041